Avalo Therapeutics, Inc.
AVTX
$9.88
$0.515.44%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -9.42% | -7.06% | 64.37% | -12.38% | -15.20% |
Total Receivables | -- | -- | -38.78% | 2,924.24% | -5.71% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 3.82% | -50.65% | 14.24% | 33.51% | 144.23% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -67.74% | 226.32% | -53.66% | -- | -- |
Total Current Assets | -9.26% | -8.60% | 61.22% | -10.16% | -13.77% |
|
|||||
Total Current Assets | -9.26% | -8.60% | 61.22% | -10.16% | -13.77% |
Net Property, Plant & Equipment | -27.71% | -21.51% | -27.78% | -5.96% | -5.42% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 60.31% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Assets | -8.62% | -8.10% | 53.10% | -9.10% | -12.46% |
|
|||||
Total Accounts Payable | 247.43% | 140.64% | -84.37% | 176.91% | -28.60% |
Total Accrued Expenses | 54.03% | -29.26% | 45.10% | -3.44% | 23.45% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -8.37% | -7.39% | 3.27% | 0.36% | 0.55% |
Total Finance Division Other Current Liabilities | 1.39% | -19.57% | -98.37% | -40.18% | -56.69% |
Total Other Current Liabilities | 1.39% | -19.57% | -98.37% | -40.18% | -56.69% |
Total Current Liabilities | 64.90% | -19.32% | -88.53% | -37.06% | -55.31% |
|
|||||
Total Current Liabilities | 64.90% | -19.32% | -88.53% | -37.06% | -55.31% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -28.36% | -21.43% | -67.68% | -8.45% | -7.65% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 25.30% | -3.58% | -25.59% | 8.43% | 64.43% |
Total Liabilities | 38.35% | -10.12% | -76.62% | -31.45% | -50.87% |
|
|||||
Common Stock & APIC | 0.55% | 0.54% | 41.38% | 3.38% | 0.14% |
Retained Earnings | -5.42% | -3.55% | -10.55% | 6.44% | 21.57% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -14.71% | -7.83% | 531.20% | 254.88% | 87.91% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -85.53% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -85.53% | 0.00% |
|
|||||
Total Common Equity | -14.71% | -7.83% | 531.20% | 254.88% | 87.91% |
Total Preferred Equity | -- | -- | -- | -85.53% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -14.71% | -7.83% | 485.17% | 1,156.90% | 97.87% |
|